TRAIL splice variant TRAILshort disrupts T cell receptor signaling and promotes immune tolerance in vivo.

Jalali S, Natesampillai S, Nie Z, Zhang Y, Can I, Chandrasekar AP, Hameister BM, Correia C, Zhao TV, Mun DG, Garcia-Rivera E, Matson R, Krogman A, Maynes MA, Batchelor R, Monie DD, Li H, Behfar A, Kenderian SS, Pandey A, Ansell SM, Taner T, Weyand C, Billadeau DD, Badley AD

Open source

DOI: 10.1172/jci194449
Published: 2026 Aug 3
Container: The Journal of clinical investigation
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1172/jci194449,
  title = {TRAIL splice variant TRAILshort disrupts T cell receptor signaling and promotes immune tolerance in vivo.},
  author = {Jalali S and Natesampillai S and Nie Z and Zhang Y and Can I and Chandrasekar AP and Hameister BM and Correia C and Zhao TV and Mun DG and Garcia-Rivera E and Matson R and Krogman A and Maynes MA and Batchelor R and Monie DD and Li H and Behfar A and Kenderian SS and Pandey A and Ansell SM and Taner T and Weyand C and Billadeau DD and Badley AD},
  year = {2026},
  journal = {The Journal of clinical investigation},
  doi = {10.1172/jci194449},
  url = {https://doi.org/10.1172/jci194449}
}

RIS

TY  - JOUR
TI  - TRAIL splice variant TRAILshort disrupts T cell receptor signaling and promotes immune tolerance in vivo.
AU  - Jalali S
AU  - Natesampillai S
AU  - Nie Z
AU  - Zhang Y
AU  - Can I
AU  - Chandrasekar AP
AU  - Hameister BM
AU  - Correia C
AU  - Zhao TV
AU  - Mun DG
AU  - Garcia-Rivera E
AU  - Matson R
AU  - Krogman A
AU  - Maynes MA
AU  - Batchelor R
AU  - Monie DD
AU  - Li H
AU  - Behfar A
AU  - Kenderian SS
AU  - Pandey A
AU  - Ansell SM
AU  - Taner T
AU  - Weyand C
AU  - Billadeau DD
AU  - Badley AD
PY  - 2026
JO  - The Journal of clinical investigation
DO  - 10.1172/jci194449
UR  - https://doi.org/10.1172/jci194449
ER  -

APA

S, J., S, N., Z, N., Y, Z., I, C., AP, C., BM, H., C, C., TV, Z., DG, M., E, G., R, M., A, K., MA, M., R, B., DD, M., H, L., A, B., SS, K., A, P., SM, A., T, T., C, W., DD, B., & AD, B. (2026). TRAIL splice variant TRAILshort disrupts T cell receptor signaling and promotes immune tolerance in vivo.. The Journal of clinical investigation. https://doi.org/10.1172/jci194449

Source records

pubmed · retrieved 2026-09-25T16:28:27.200Z